PMCH and metabolic disease: Patients with metabolic disease had a higher BMI (33.70 ± 1.30 vs. 29.95 ± 4.58, p = 0.008), higher PLT levels (379.00 ± 22.50 vs. 316.95 ± 34.00, p = 0.034), and higher MCH (31.40 ± 1.03 vs. 28.55 ± 1.80, p = 0.002) relative to patients without metabolic disease.